Walter Dunn

Title: Walter Dunn - Innovator in Antiviral Research

Introduction

Walter Dunn is a prominent inventor based in Cupertino, CA (US). He has made significant contributions to the field of antiviral research, particularly in understanding the cytomegalovirus (CMV) and its implications for developing effective treatments and vaccines.

Latest Patents

Walter Dunn holds a patent for "Cytomegalovirus gene function and methods for developing antivirals, anti-CMV vaccines, and CMV-based vectors." This patent involves a global functional analysis of human cytomegalovirus (HCMV) genes. The research includes constructing virus gene-deletion mutants and examining their growth phenotypes in various natural HCMV host cells. This systematic analysis identified 45 viral open reading frames (ORFs) essential for viral replication and characterized 115 growth-dispensable viral genes. Notably, the findings reveal that HCMV encodes genes known as temperance factors, which repress its own replication on a cell type-specific basis. This research suggests that pathogen temperance may be a strategy employed by other infectious agents to enhance their long-term survivability within their respective host populations.

Career Highlights

Walter Dunn is affiliated with the University of California, where he continues to advance his research in virology and antiviral development. His work has garnered attention for its innovative approach to understanding viral behavior and developing potential therapeutic strategies.

Collaborations

Walter collaborates with notable colleagues, including Cassie Chou and Fenyong Liu. Their combined expertise contributes to the ongoing research and development of antiviral solutions.

Conclusion

Walter Dunn's innovative work in the field of antiviral research, particularly regarding cytomegalovirus, highlights his significant contributions to science and medicine. His patent and ongoing research efforts pave the way for future advancements in antiviral therapies.